Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients

PURPOSE: Tacrolimus is recommended by KDIGO Clinical Practice Guidelines as an initial therapy for the treatment of membranous nephropathy (MN). However, little is known about the factors that influence response and recurrence of the disease after tacrolimus therapy, and there are limited data regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shuang, Liang, Yan-Jun, Li, Zhao, Wang, Yong, Guo, Xin-Ru, Zhang, Chao-yang, Zhang, Chun, Wu, Jie, Wang, Xiao-Long, Li, Yi-Sha, Cai, Guang-Yan, Chen, Xiang-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106312/
https://www.ncbi.nlm.nih.gov/pubmed/37077772
http://dx.doi.org/10.2147/TCRM.S399218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106312/
https://www.ncbi.nlm.nih.gov/pubmed/37077772
http://dx.doi.org/10.2147/TCRM.S399218

Ejemplares similares